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SHORT TITLE: Valuing health for economic evaluation in child and adolescent populations 
 
ABSTRACT 
Methods for measuring and valuing health benefits for economic evaluation and health 
technology assessment in adult populations are well developed. In contrast, methods for 
assessing interventions for child and adolescent populations lack detailed guidelines, 
particularly regarding the valuation of health and quality of life in these age groups. This 
paper critically examines the methodological considerations involved in the valuation of child 
and adolescent-specific health related quality of life by existing preference-based measures. 
It also describes the methodological choices made in the valuation of existing generic 
preference-based measures developed with and/or applied in child and adolescent 
populations: AHUM, AQoL-6D, CHU9D, EQ-5D-Y, HUI2, HUI3, QWB, 16D and 17D. The 
approaches used to value existing child and adolescent-specific generic preference-based 
measures vary considerably. Whilst the choice of whose preferences and which perspective 
to use is a matter of normative debate and ultimately for decision by reimbursement 
agencies and policy makers, greater research around these issues would be informative and 
would enrich these discussions. Research can also inform the other methodological choices 
required in the valuation of child and adolescent health states. Gaps in research evidence 
are identified around: the impact of the child described in health state valuation exercises 
undertaken by adults including possibility of informed preferences; the appropriateness and 
acceptability of valuation tasks for adolescents in particular tasks involving the state ‘dead’; 




 The paper critically examines the methodological considerations involved in the 
valuation of child and adolescent-specific preference-based measures 
 The paper concludes that whilst the choice of whose preferences and which 
perspective to use is a matter of normative debate, and ultimately for decision by 
reimbursement agencies and policy makers, greater research around these issues 
would be informative and enrich these discussions 
 Gaps in research evidence are identified, including the anchoring of adolescent 
preferences for the calculation of quality-adjusted life years (QALYs), and generation 
and use of combined adult and adolescent preferences 
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Economic evaluation is increasingly used to inform resource allocation decisions in 
healthcare, often assessing benefits using quality adjusted life years (QALYs) or disability-
adjusted life-years (DALYs). The methodology for assessing interventions and measuring 
and valuing  health benefits in adult populations for economic evaluation is well developed, 
including detailed guidance from many international agencies (for example [1-2]), and good 
practice guidelines, for example ISPOR guidance [3-4]. However, the methods for assessing 
interventions for child and adolescent populations in particular often lack detailed guidelines, 
or implicitly assume that what is recommended for adults is also what it most appropriate for 
children and adolescents, despite there being special considerations for children (see for 
example [5]). One important aspect concerns the valuation of health and/or quality of life for 
child and adolescents for use in health technology assessment and economic evaluation, in 
particular to generate QALYs. 
The Quality Adjustment weight of the QALY is often generated through application of a 
preference-based measure accompanied by off-the-shelf utilities. Preference-based 
measures can be generic or condition-specific, and population-specific, including child and 
adolescent measures as well as adult measures. A child and adolescent preference-based 
measure is designed to measure and value the health of children typically aged from around 
7 to 17 years (specific target ages vary between measures and there are cases where they 
are used from age 4, for example CHU9D [6]). Adult measures are generally designed to 
measure and value the health of adults aged 18 onwards. Some measures are intended for 
use in children, adolescents and adults (for example HUI2 and HUI3).  
Child and adolescent measures differ to adult measures in important ways (see [7] for an 
overview). For example, child and adolescent measures may regularly need to be proxy-
reported by carers as well as self-reported, since younger (aged below 7) and intellectually 
impaired respondents may be unable to self-report their own health. This raises important 
considerations around the classification systems used to measure health (for further 
discussion see [8-11]), for example content that must be appropriate and understandable as 
the person ages, and suitable for both self-report and proxy report (see for example [12] for 
issues around self and proxy-reporting).  
However, one potential key difference between adult and child and adolescent-specific 
preference-based measures relates to their value sets, the scoring to generate utilities for 
economic evaluation, and this is the main focus of this paper. The valuation of any 
preference-based measures requires methodological decisions: whose preferences; which 
perspective; elicitation technique and mode of administration. If the elicitation technique 
does not produce scores onto the QALY scale, then methods to anchor onto the 1-0 full 
health-dead scale required for economic evaluation are needed. Some of these 
methodological questions differ for child and adolescent measures in comparison to adult 
measures, and whilst many can be informed by research some are normative and ultimately 
require a value judgement. Some international agencies also have requirements around the 
methods used to generate value sets for measures used in health technology assessment 
(for example see [1]). The issue of comparability with adult utilities and consistency of 
technology assessments across conditions and populations should be considered. It is also 
important to consider the comparability to adult utilities within a condition and within a cost-
effectiveness model, as QALYs may include impacts on length of life and quality of life from 
childhood into adulthood. 
 
The aims of this paper are to: 1) to identify current available child and adolescent-specific 
generic preference-based measures; 2) summarise and provide a critical assessment of the 
methodological considerations in the valuation of child and adolescent-specific preference-
based measures; 3) review the existing literature on generating value sets for child and 
adolescent preference-based measures; and 4) identify current gaps in research evidence 
and methods regarding valuation of child and adolescent-specific preference-based 
measures.  
 
2.0 Child and adolescent-specific generic preference-based measures 
A recent review [13] of generic multi-attribute preference-based instruments in paediatric 
populations has identified and provided an overview of the measures AHUM [14], AQoL-6D 
[15-16], CHU9D [6,17-25], EQ-5D-Y [26-29], HUI2 [30-31], HUI3 [32] QWB [33], 16D [34] 
and 17D [35], that are summarised in Table 1.  
This review focusses on child and adolescent-specific generic preference-based measures, 
though there are some examples of child and adolescent-specific condition-specific 
preference-based measures (for example for dermatitis [36] and asthma [37]) with others 
also in development.  
 
3.0 Methodological considerations in the valuation of child and adolescent-specific 
measures 
This section outlines the main issues and critically assesses options available to 
researchers, clinicians and other key stakeholders. Decisions relating to valuation may be 
influenced by the measure under consideration or by recommendations from reimbursement 
agencies. However, several important methodological considerations in the valuation of child 
and adolescent-specific measures can be informed by economic theory and research, for 
example by identifying good practice through understanding the strengths and limitations of 
different approaches when applied in different modes of administration, to different 
populations, using different perspectives. Table 2 presents an overview of key 
methodological considerations in this context.  
 
3.1 Whose preferences 
Utilities that are used to generate the value set for preference-based measures can be 
elicited from adults (members of the general public, parents, or healthcare professionals), 
young adults, adolescents and children. The choice of whose preferences is important, and 
research has shown that different populations provide different preferences [22, 38-39] and 
arguments can be made to involve the differing perspectives of both child and adult 
preferences in medical decision making [40]. 
 
Adult preferences 
Adult preferences can be advocated on the grounds that adults ultimately fund healthcare 
through taxation, and hence their preferences should be used to determine how healthcare 
resources are allocated. Value sets for preference-based measures for adults are typically 
generated using adult general population preferences elicited for hypothetical health states, 
and hence it can be argued that the elicitation of adult preferences for child and adolescent-
specific preference-based measures can provide comparability in the methodology used to 
elicit preferences for adults, children and adolescents. However, whilst this provides 
comparability in the population used to elicit preferences, this does not guarantee 
comparability in the utilities that are elicited, for example see the discussion below around 
perspective. The comparability in methods but not the resulting utilities can generate issues 
for HTA where utilities are modelled over time as the patient ages from childhood through 
adulthood.  
In general it may be argued that adults have a greater understanding than children and 
adolescents of preference elicitation tasks, that can be cognitively demanding both in terms 
of understanding the task and being able to make a choice (though this will differ at the 
individual level) [19]. In addition, it is widely regarded as being ethically acceptable to ask 
adults to compare health states to being dead, without causing unnecessary distress. 
However, whilst adults may have greater cognitive understanding of the tasks, they may not 
understand the child and adolescent health states and their impact, and this is something 
discussed further below regarding perspective. In addition, previous research has 
demonstrated that adult preferences can differ to child and adolescent preferences [22], and 
therefore utilities derived from adult preferences should not be viewed as interchangeable 
with those derived from children and adolescents. 
 
Child and adolescent preferences 
Child and adolescent preferences can be argued for on the grounds that it is children and 
adolescents who experience the health states, and some institutions regard adolescent 
views as an important consideration for any assessment of health interventions [41-44]. 
However, younger children aged around 7-10 years of age are unlikely to fully understand 
the tasks and unlikely to be able to make a choice. The ability to understand and choose is 
impacted not only by age but also may be impacted by educational ability, experience of ill 
health and socio-demographic characteristics, meaning some younger children may be able 
to undertake these tasks and some older children may be unable to undertake them [45]. 
The type of elicitation approach adopted, the number of tasks that are presented, framing of 
questions, the complexity of wording, the number of dimensions in health states, and health 
state selection for valuation (and comparisons) may also affect the difficulty of the tasks (for 
an example of how methodological choices may impact see [45]). Presentation and design 
can be tailored to the population asked to value health states to ease comprehension and 
reduce difficulty, for example colour coding to highlight differences/similarities, 
boldening/graying of severity levels, allowing dimensions to vary for only a subset of 
dimensions within or between tasks (for an example of these types of approaches in an adult 
population see [46]). Research has found internally valid responses for adolescents valuing 
hypothetical health states using best-worst scaling and DCE, suggesting that an appropriate 
selection of task, design, framing and presentation can be used to elicit adolescent 
preferences where respondents have good understanding and make reasoned choices 
[22,47, 48]. It should be noted that when applying the best-worst scaling approach in the 
valuation of CHU9D states worst choices were far less consistent than best choices [22]. 
This tendency was also evident in the valuation of CHU9D health states using an adult 
sample but was found to be more prevalent in adolescents. However, such phenomenon 
was not observed in the valuation of EQ-5D-Y health states in different samples of 
adolescents and adults in two countries [48]. Other research examining the elicitation of 
preferences for hypothetical health states has found that children aged 10-17 can complete 
best-worst scaling tasks, and children aged 14-17 years can undertake pairwise comparison 
tasks [45]. 
Questions have been raised around the acceptability and appropriateness of asking 
preference elicitation tasks that involve consideration of the state of being dead with 
adolescents. This raises two issues: first whether adolescents are able to understand and 
make reasoned choices in questions involving consideration of being dead; and second 
whether the use of elicitation techniques involving consideration of being dead would cause 
distress or upset for adolescents and therefore cause concerns for research ethics 
committees. Some studies have been undertaken involving consideration of being dead with 
adolescents [49], suggesting that if appropriate design and framing is used these tasks may 
be appropriate, and further guidance for ethics committees is required for this to be an option 
pursued in the future as currently there is little guidance on these issues. 
The inability of younger children to value health states raises the issue of whether it is more 
acceptable for adolescents than adults to value health states experienced by young children. 
Either argument can be made around whose preferences should be used to value health 
states for young children, but for these children their own preferences cannot be taken into 
account, meaning that it is a normative decision around whose preferences to use.  
 
Hypothetical preferences, experience-based preferences or patient preferences 
Preferences can be elicited for hypothetical health states, where people imagine health 
states, termed hypothetical general population preferences, and these could be provided by 
general population adults or adolescents. However it is possible to ask adolescent patients 
in ill health, to value hypothetical health states, and this is referred to as patient preferences. 
Another alternative is to ask adolescent patients in ill health to value their own health state, 
which generates experience-based preferences.  An experience-based value set has been 
estimated for the EQ-5D-Y in Canada, which estimates a regression with own VAS as the 
dependent variable and the EQ-5D-Y classification system as the independent variables 
from respondents aged primarily 10 to 11 years [50], though note that this uses a 1-0 scale 
where 1 equals best state and 0 equals worst state. There are theoretical and practical 
arguments around the advantages and limitations of both experience-based preferences [51] 
and patient preferences [52] that have been discussed for adult utilities, and many of these 
arguments are likely to apply for child and adolescent-specific preference-based measures.  
 
Combined preferences  
One option is to extend the definition of the general population to include adolescents when 
valuing health states, to generate a value set that combines both adult and adolescent 
preferences together. Since adolescent and adult preferences may differ, sampling 
strategies around age and gender would need to be carefully considered to achieve an 
appropriate sample. Alternatively, both adolescent and adult value sets could be generated 
and both used to inform analyses (for an analogous argument for general population and 
patient preferences see [52]; this is also relevant for the 2nd Washington Panel on Cost 
Effectiveness [53]). However, careful consideration of the appropriate elicitation technique 
and perspective would be required.  
 
Informed preferences 
Informed preferences have been used in the elicitation of adult utilities as a way of obtaining 
preferences from the general population that are more informed about what it is like to live in 
ill health using information from patients experiencing health states [54]. This technique 
could be used to provide adolescents more information about what it is like to experience ill 
health, since their experiences of ill health may be limited; or could be used to provide adults 
more information about how ill health impacts on children and adolescents when they are 
valuing health states in the context of imagining what it is like for a child (see section on 
perspective below). For example, information that is provided could involve child and 
adolescent experience-based preferences (see section above), or child and adolescent 
patient preferences (see section above). This is not something that we are aware has been 
undertaken in the literature, and further research may be worthwhile.  
 
3.2 Perspective 
In hypothetical health state valuation tasks participants are asked to imagine someone in a 
health state, and indicate how good or bad the health state is for that person. The term  
perspective’ is used to indicate who the person is that they are imagining is experiencing the 
health state, for example, the person could be themselves, a child, or another adult. The 
elicitation of preferences from adolescents would usually involve valuation from their own 
perspective, where they are imagining that they are experiencing the health state. However, 
adolescents could be asked to value health states experienced by someone else, an ‘other’ 
perspective, but this is likely to be more cognitively challenging.  
The elicitation of preferences from adults can involve multiple different perspectives: own 
health as an adult; health state for themselves as a child; health state in the context of a 
child at a specified age; health state for another adult. 
Own perspective for adults can be argued for on the basis that the adult is under a ‘veil of 
ignorance’ where they do not know who is experiencing the health state, and hence the 
value they provide is not influenced by any views around children or child health. It can be 
argued that this provides comparability with the methodology used to elicit hypothetical adult 
preferences for adult health states. In addition, if child health is valued more highly by 
society than adult health, this can be taken into account in the resource allocation process 
using, for example, QALY weighting or deliberation, where there is no risk of double counting 
as the utilities are not in any way influenced by participants preferences around child health. 
However, the classification system of child and adolescent-specific preference-based 
measures may involve terms that are inappropriate for adults, for example CHU9D mentions 
homework and schoolwork in one dimension (though there is an adult version that instead 
refers to work [22]). If these were to remain in their original wording this would likely cause 
confusion and a lack of engagement, and would lead participants to the view that they are 
being asked to imagine themselves as a child. Alternatively some dimensions can be 
reworded, meaning that the definition of this dimension is not analogous to the aspect of 
health-related quality of life that the child or adolescent are reporting using the classification 
system, creating a discrepancy in what is valued in the value set and what is reported using 
the measure [24,55]. Another example is daily routine, where although the dimension would 
not be reworded in a valuation task, a child’s daily routine will differ to the daily routine adults 
imagine for themselves. 
Adults could be asked to imagine the health state in the context of a child of a specified age, 
where often a 10 year old child is specified though this could be any age. However, the child 
that the participant imagines may matter: whether for example it is their own child, 
grandchild, child they have strong feelings about, or a child they do not know. These 
preferences may be influenced by participants’ views about children and child health, 
meaning that the elicited preferences may include both how good or bad the health state is, 
but also how good or bad it is that the child they are imagining is in this state of ill health. It 
can be argued that the use of these preferences to inform policy, for example to generate 
QALYs for HTA, should take this into consideration, since any QALY weighting or 
deliberation that gives a higher weight to child health relative to adult health may be double 
counting. There is also the issue around the age of the child that adults should be asked to 
imagine. There is a possibility that the age of the child participants are asked to imagine 
impacts on preferences, and this is an area currently under research. 
Adults could be asked to imagine the health states for themselves as a child, but this is 
prone to recall bias, as they will not be able to accurately recall what it was like to be a child. 
Their preferences may also be influenced by views around child health, their childhood and 
their experiences as a parent/guardian if they have children. 
 
3.3 Elicitation technique and mode of administration 
Table 2 outlines the different preference elicitation techniques that can be used in studies 
eliciting valuations from adolescents and adult populations: best-worst scaling; discrete 
choice experiment (DCE); ranking; rating scale/visual analogue scale (VAS); DCE with 
duration; time trade-off; standard gamble. Each of these elicitation techniques is theoretically 
plausible for use with adolescents and adults, though there may be ethical and practical 
concerns around the acceptability and appropriateness of use of some of these techniques 
in adolescents. 
Best-worst scaling, ranking and discrete choice experiment are all ordinal techniques that 
provide relative weightings of dimensions and severity levels, and are all generally 
considered as being easy to understand. These methods do not require any consideration of 
being dead, and so are considered ethically acceptable and appropriate for use in 
adolescents. However, all these methods only generate anchored preferences onto the 1-0 
full health-dead scale if there is mention of being dead and duration of health states. For 
example in DCE with duration this is achieved by including duration as an additional attribute 
[56-57] (see section below for methods of anchoring).  VAS tasks do not require inclusion of 
dead as a state in the task, but if dead is included the generated preferences can be directly 
anchored onto the 1-0 full-health-dead scale.  
Best-worst scaling has been criticised in the literature when used to value health states in 
adults, and a small number of studies have found that the preferences it generates differ to 
other elicitation techniques [58-59], though further research studies examining this are 
recommended. DCE may be cognitively challenging particularly where there are several 
dimensions of health and these vary across the profiles within a choice set. Ranking over a 
large number of health states can become laborious and time consuming with a large 
amount of reading and recall of the other states each state is being ranked alongside. VAS 
has been criticised in the literature as it does not involve sacrifice or opportunity cost 
meaning that it may not accurately reflect the value of a health state, though there is no 
consensus on this issue [60]. Participants have been found to spread the set of states (or 
dimensions) they are valuing across the scale, meaning that the value of states can be 
impacted by the states they are valued alongside, avoid the ends of the scale, and display a 
tendency to prefer numbers ending in 5 or 0 (50, 55, 60) [61] though digit preferences can 
also be observed using other cardinal elicitation techniques. However in VAS valuation 
studies the impact of these may be reduced through careful design.  
Time trade-off, standard gamble and DCE with duration are cardinal techniques that 
generate utilities on the 1-0 full health-dead scale. These techniques involve imagining being 
dead, and as discussed above, questions have been raised around the acceptability and 
appropriateness of asking adolescents to complete these tasks. An option to remove 
consideration of dead is chained time trade-off or chained standard gamble, where an 
impaired health state is valued relative to a worse health state, with no mention of dead. The 
utility for the impaired health state is then anchored on the 1-0 full health-dead scale using 
the utility for the worse health state which is elicited using standard time trade-off or standard 
gamble, and these utilities could be elicited from adults (see the section below on anchoring 
for discussion of some of the issues this raises). DCE with duration has not to our knowledge 
been undertaken with adolescents, and may be too cognitively challenging since it involves 
both trading between length of life and health and simultaneously considering multiple 
profiles of health. DCE with duration will not generate appropriate responses if respondents 
do not trade between length of life and health, and hence this should be established prior to 
use of this technique. Standard gamble involves consideration of risk, and adolescents may 
have different attitudes to risk than adults which could impact on elicited standard gamble 
preferences. Time trade-off is often used to generate value sets for adult preference-based 
measures, and the use of this technique may provide greater comparability of methods used 
to generate adult value sets for these measures, provided this can be used appropriately 
given the methodological choices of whose values and which perspective to use in the 
valuation survey. 
The choice of perspective combined with technique should be carefully considered since this 
can impact on preferences. Research using visual analogue scale has shown that adults 
valuing health states from the perspective of a child of a specified age can generate lower 
utilities than adults valuing health states for themselves [62]. However the reverse has been 
found using time trade-off where participants trade between health and length of life to 
indicate their preferences for health states, where utilities elicited using an adult own health 
perspective can be lower that utilities elicited considering the perspective of a child [55] i.e. 
adults were less willing to trade off length of life for children. Potentially this may also occur 
for DCE with duration and standard gamble due to the risk of death. Potentially this may 
occur because participants are more unwilling to state that a child should die sooner than to 
state that they themselves should die sooner.  
Valuation studies for adult preference-based measures have been conducted using online 
surveys, computer assisted personal interviews (CAPI), face-to-face interviews and hall tests 
across a range of different elicitation techniques, and table 2 highlights the use of classroom 
tests for adolescents. Appropriate design, framing and presentation can make a difference 
not only around the appropriateness of the task but also around the appropriateness of the 
mode of administration used to elicit preferences, and careful piloting is recommended.  
 
3.4 Anchoring 
Best-worst scaling, ranking and discrete choice experiment do not automatically provide 
utilities that are anchored onto the 1-0 full health-dead scale (see discussion above about 
the protocols that enable these methods to directly generate utilities on the 1-0 scale). This 
presents the key challenge of how to anchor these utilities onto the 1-0 full health-dead 
scale. Anchoring requires the use of utilities for the classification system that are anchored 
onto the 1-0 full health-dead scale, and these could be elicited using time trade-off, standard 
gamble or DCE with duration.   
Possible methods for anchoring include: mapping the ordinal preferences via regression 
analysis to cardinal utilities; rescaling using cardinal utilities for worst state/small numbers of 
states; and a hybrid model simultaneously modelling both ordinal and cardinal data [61] (to 
our knowledge the hybrid model has not been currently applied to the valuation of child 
health states). Both the mapping method and hybrid model have been found to be more 
accurate at predicting time trade-off utilities when mapped from DCE preferences than the 
rescaling method [63]. The mapping method approach will simply anchor the ordinal 
preferences, whereas the hybrid model will simultaneously consider both the ordinal and 
cardinal data and hence will produce utilities that combine the data. The selection of which 
method to apply may therefore depend upon whether the researcher or policy maker aims to 
generate combined preferences. For example, in the case of the elicitation of adolescent 
preferences, the mapping approach may be selected if adult preferences are obtained solely 
for the purpose of anchoring, rather than to generate combined value sets. The anchoring of 
utilities for child and adolescent preference-based measures in particular is an important 
area that has been under-researched and has not been fully debated to date. 
 
4.0 Review of methods used to generate value sets for child and adolescent-specific 
generic preference-based measures 
Table 3 provides a summary of the value set methodologies of child and adolescent-specific 
generic preference-based measures. Note that AHUM, CHU9D, EQ-5D-Y, 16D and 17D are 
the only measures intended only for use in children and/or adolescents, all of the other 
measures are also appropriate (and derived) for use in adults. For a more detailed overview 
of each valuation study of each measure see [13].  
There is no consensus in the methodology used in the valuation across the measures, for 
the case of the CHU9D, HUI2 and EQ-5D-Y for valuations in different countries, and for the 
16D and 17D across a suite of measures.  
 
4.1 Whose preferences 
Adolescent preferences are solely used to generate value sets for AQoL-6D and 16D; 
adolescent preferences anchored using young adult preferences are used to generate 
CHU9D value sets in Australia and China; adult general population preferences are used to 
generate value sets for AHUM, CHU9D in the Netherlands and UK, EQ-5D-Y in the US, 
HUI2 in the UK, HUI3 and QWB; parent preferences are used to generate value sets for 
HUI2 in Canada and 17D.  
Samples 
Sample size ranges from 115 for AQoL-7D to 4155 for EQ-5D-Y. Some differences in 
sample size would be expected due to differences in the elicitation technique and mode of 
administration as well as the choice of modelling and selection of health states for valuation. 
However, three samples are below 200 (HUI2 valued in Canada and UK and 17D). Sample 
representativeness in terms of the approach used to ensure that the sample is 
representative of the population varies across the studies. The 16D and 17D studies 
recruiting children and adolescents recruited both school children and patients, whilst 
CHU9D in China recruited only school children to form the adolescent sample and CHU9D in 
Australia recruited a community-based sample via parents. Most of the studies involving 
adult general population aimed to obtain national representativeness, with the notable 
exceptions that AHUM recruited participants both by word of mouth and an existing panel of 
potential participants and the sampling method is not specified for the AQoL-6D valuation. 
Three of the studies were published in 1996 (HUI2 Canada, 16D, 17D), one study in 2002 
(HUI3), one study in 2005 (HUI2 UK), one study in 2008 (QWB) and the remainder 2010 
onwards. However, many of the valuation studies may have been conducted many years 
prior to publication, for example the HUI3 valuation was undertaken in 1994. 
 
4.2 Perspective 
Adolescent preferences are elicited using their own perspective. Valuation studies where 
parent preferences are elicited use the perspective of a 10 year old child for HUI2 in Canada 
and a child aged 8-11 for 17D. Valuation studies where adult general population preferences 
are elicited use their own perspective for AHUM, CHU9D in the UK and the Netherlands, and 
HUI3, and use the perspective of a 10 year old child for HUI2 in the UK and EQ-5D-Y in the 
US.  
 
4.3. Elicitation technique and mode of administration 
There is considerable variation in the preference elicitation tasks used, with AHUM and 
AQoL-6D using time trade-off, CHU9D using different techniques in different countries with 
best-worst scaling and time trade-off, discrete choice experiment with duration, and standard 
gamble, HUI2 and HUI3 using standard gamble and visual analogue scale, EQ-5D-Y using 
discrete choice experiment with duration and QWB, 16D and 17D using a VAS. Adolescent 
preferences are elicited in a classroom setting and online survey, and adult preferences are 
elicited using face-to-face interviews and online surveys.  
 
4.4 Anchoring 
Most studies employ techniques that are directly elicited using conventional valuation 
approaches on the 1-0 full health-dead scale, with the exception of CHU9D in Australia and 
China. Both HUI2 value sets and the HUI3 value set apply multi-attribute utility theory to 
combine standard gamble and visual analogue scale data. 
 
5.0 Discussion 
This paper has critically examined the methodological considerations involved in the 
valuation of child and adolescent-specific measures, with reference to the methodological 
choices made to date in the valuation of child and adolescent-specific generic preference-
based measures. The approaches used to value existing child and adolescent-specific 
generic preference-based measures are varied, with no commonality across the measures, 
or for some measures, within the choices made to value the measure in different countries. 
Sample size for some studies is small (HUI2 Canada [30] and UK [31] and 16D [34]) given 
the size of the classification systems and the intended use of the valuation study to generate 
value sets for use to inform policy. Some of the value sets were published over 20 years ago 
[30,34,35] (and the valuation studies underpinning these are likely to have been undertaken 
years earlier), and preferences may have changed over this time and there have been 
methodological advances in the health valuation literature. The methodological choices 
made to generate existing value sets indicate both what has been done and what is 
possible, yet there are many possibilities for future research around both what else could be 
done, and scope for recommendations around good practice. Whilst many of the 
considerations are normative, meaning it is perfectly acceptable and expected that a range 
of approaches are used to generate existing value sets, both economic theory and empirical 
research can be used to generate good practice guidelines and maximise the quality of 
research in this area.  
Currently there is limited guidance from international agencies around how to generate 
QALYs and hence utilities for use in health technology assessment of interventions affecting 
young populations. For example, whilst the NICE Methods Guide is prescriptive for the 
methods that should be used to generate utilities for adults, limited guidance is given around 
how to generate, source and model utilities for child and adolescent-specific states. Recent 
reviews have found that child and adolescent-specific preference-based measures have 
been used only a handful of times in health technology assessments covering children and 
adolescents submitted to NICE [64], and published cost-utility analyses for child and 
adolescent populations [65], and that a large range of diverse methods are used to generate 
published utilities for children and adolescents [66-68].  
The limited use of child and adolescent-specific preference-based measures to reflect the 
health and quality of life of children in health technology assessment is concerning, since we 
are not aware of an evidence base demonstrating that adult preference-based measures 
(such as EQ-5D-3L) appropriately and accurately capture the health and quality of life of 
children and adolescents. Evidence is required to examine the representativeness of adult 
measures self-completed by adults for their own health as a proxy for capturing the health of 
a child with the same condition, since this type of evidence has been used to inform health 
technology assessments [64]. In addition evidence demonstrating head-to-head 
comparisons of adult preference-based measures and child and adolescent specific 
preference-based measures would enable greater understanding of the impact of using an 
adult or child and adolescent-specific measure to measure the health of a child and 
adolescent.  
The issue of comparability and consistency of utilities generated by child and adolescent-
specific preference-based measures and utilities generated by adult measures is important, 
since for health technology assessment utilities are modelled over time as the patient ages 
from childhood through adulthood. Whilst it can be argued that the use of comparable 
valuation methodology for different preference-based measures can be used to ensure 
consistency when considering evidence generated using different measures (see for 
example [69] for this argument around condition-specific and generic preference-based 
measures), this does not ensure comparability in the actual utilities that are used. This is 
important if utility changes as the patient ages due to a change in preference-based 
measure or from proxy to self-reporting despite no change in health. 
Use of measures such as HUI2 and HUI3 that are appropriate for use across children, 
adolescents and adults have the advantage of consistency and comparability of utilities 
across all ages of patients. The combination of utilities generated using EQ-5D-3L and EQ-
5D-Y can also arguably provide some consistency in terms of the domains of health 
assessed, if it is appropriate to assume that domain content is the correct criteria of 
consistency. The CHU9D measure does have an adult version, but use of this measure in 
adults can be questioned since the content of the classification system was developed with 
children aged 7 to 11 [6,17-18]. 
It is unclear why child and adolescent-specific preference-based measures have not been 
used to a larger extent to generate utilities for child and adolescent-specific states. 
Potentially this could be for many reasons that are not mutually exclusive, including: a 
concern around the psychometric performance of these measures; limited uptake of child 
and adolescent preference-based measures in trials or other studies used to generate data 
for use in health technology assessment; concern around the appropriateness of existing 
value set utilities, methodology or in the case of EQ-5D-Y lack of a value set; concern 
around the scope and focus of these measures and whether they capture all important 
outcomes for health and social care; or a concern around the use of these measures 
alongside adult utilities generated using an adult generic preference-based measure and 
how to combine these utilities. Another potential reason may be that there is less emphasis 
placed on cost-effectiveness when making resource allocation decisions for children and 
adolescents. In addition the absence of recommendations for the use of child and 
adolescent-specific measures in guidelines by international agencies is likely to be an 
important factor contributing to their limited usage and developing these recommendations 
would encourage greater usage of these measures and would be an important step forward.  
In the future there are likely to be more child and adolescent-specific generic preference-
based measures, since there are existing child and adolescent-specific generic measures 
currently undergoing valuation in order to make them preference based, including PedsQL 
[70] (note there is also an adult version), and other measures that are amenable to valuation 
and that may be valued in the future, for example PROMIS [71]. At the time of preparation of 
this manuscript, the EuroQol Group is developing an international valuation protocol for the 
development of country-specific EQ-5D-Y value sets. This protocol has been informed by 
completed or in-progress studies funded by the EuroQol Group that has investigated: 1) 
whether current EQ-5D-3L value sets can be appropriately used with EQ-5D-Y health states 
[55,62]; 2) the development of a latent scale value set in the UK using adults and adolescent 
samples [39,47]; 3) the evaluation of different anchoring alternatives to latent scale value 
sets from discrete choice experiments [72]; and 4) the impact of using different perspectives 
when completing DCE with duration tasks to estimate an EQ-5D-Y value set. 
The issue of measuring and valuing benefits for children and adolescents cannot be 
considered in isolation, since the impact of ill-health reaches wider than the child or 
adolescent to other family members. There is an important literature around the use of a 
family perspective in economic evaluation for children and adolescents to include spillover 
effects and also around joint utility estimation [5,8-9,73-76] and this is an area that deserves 
consideration by international agencies when they consider whether to make special 
recommendations around measuring and valuing health benefits in child and adolescent 
populations for economic evaluation. 
The topic of this paper can be discussed in relation to welfarism and extra-welfarism. 
Welfarism has a clear theoretical position on whose preferences count in social choices, 
though the literature as far as we are aware does not have special considerations for 
children or adolescents. However, QALYs and cost-effectiveness analysis are grounded in 
extra-welfarism, and extra welfarism offers no such guidance. This means that the normative 
issues that we discuss in the paper require quite strong value judgements. 
This review has examined the methodology around valuation of measures aimed at 
measuring and valuing the health and quality of life of children and adolescents aged 5 
years and above. There are added complications of generating utilities for children below 
age 4, where none of the generic preference-based measures are recommended for use, 
meaning that there is little scope for the measurement and valuation of health and quality of 
life for children of this age as reported by carers/parents. There is a quality of life measure 
for infants and toddlers [77-79], the infant and toddler quality of life questionnaire (ITQOL), 
but it is not preference-based. Valuation for health and quality of life for this age group would 
also present new challenges, since what is within a normal developmental range widely 
varies within the 0-4 age range, and any generated utilities may need to capture impairment 
in comparison to the normal developmental range, rather than the normal developmental 
stage. For example, a newborn baby will not be able to walk or talk, but arguably should not 
have a utility decrement reflecting their inability to walk or talk; whereas a 4 year old within 
the normal developmental range would walk and talk, and any impairment would likely be 
associated with a utility decrement. Therefore, whilst QALYs can be used to capture health 




This paper has summarised and critically assessed the methodological considerations 
involved in the valuation of child and adolescent-specific measures; and reviewed the 
methodological choices made to generate value sets for child and adolescent generic 
preference-based measures. This paper has also identified gaps in research evidence and 
methods regarding valuation of child and adolescent health states, in particular around: 
Whose preferences: the collection of experience-based utilities; the elicitation of 
patient preferences; possibilities for the combination of utilities elicited from adults 
and adolescents; whether there is a role and how to elicit informed preferences 
where child and adolescent experience can be used to inform elicitation tasks 
undertaken by adolescents or adults; 
 
Perspective: whether the age and description of the child impacts on preferences 
elicited by adults valuing from the perspective of the child; 
 
Elicitation technique: greater guidance around when consideration of being dead is 
both appropriate and acceptable for inclusion in tasks completed by adolescents; and 
how to ensure tasks are designed and framed appropriately for adolescents; 
 
Anchoring: greater exploration of the anchoring of adolescent preferences using 
techniques applied in the valuation of adult preference-based measures.  
Valuation of child and adolescent-specific preference-based measures is a challenging area 
of research that warrants further empirical evidence to inform best practice guidelines. Many 
international agencies will have a view on this, and other stakeholders including the general 
public, carers/parents and patients, and their views as well as economic theory will ultimately 
determine both the research agenda and what methodology is selected.  
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Table 1: Summary of the classification systems of child and adolescent-specific generic preference-based measures 
Measure Age appropriate 
to measure 
health for (years) 








AHUM 12-18 Self-care; pain; limitations walking around 
(mobility); perceptions of strenuous activities; self-
image; health perceptions 
6 4-7 16,800 [14] 
AQoL-
6D 
Unclear Independent living; relationships; mental health; 
coping; pain; senses 
6 4-6 7.8x1013 [15] 
CHU9D 4-17 Worry; sadness; pain; tiredness; annoyance; 
school; sleep; daily routine; activities 
9 5 1,953,125 [6,17-18] 
EQ-5D-
Y 
4-15 Mobility; looking after myself; doing usual activities; 
having pain or discomfort; feeling worried, sad or 
unhappy 
5 3 243 [26-28] 
 
HUI2 5 upwards Sensation; mobility; emotion; cognition; self-care; 
pain; fertility 
7 3-5 24,000 [30] 
HUI3 5 upwards Vision; hearing; speech; ambulation; dexterity; 
emotion; cognition; pain 
8 5-6 972,000 [32] 
QWB Unclear Chronic symptoms or problems; acute physical 
problems; mental health; mobility; physical activity; 
social activity  
3 plus 58 
symptoms 
2-4 945 [33] 
16D 12-15 Mobility; vision; hearing; breathing; sleeping; eating; 
elimination; speech; mental function; discomfort 
and symptoms; school and hobbies; friends; 
physical appearance; depression; distress; vitality 
16 5 1.5x1011 [34] 
17D 8-11 Mobility; breathing; school and hobbies; friends; 
hearing; vision; eating; elimination; vitality; sleeping; 
anxiety; discomfort and symptoms; learning and 
17 5 7.6x1011 [35] 
Measure Age appropriate 
to measure 
health for (years) 












Table 2: Considerations and study characteristics in the valuation of child and adolescent-specific-specific measures 
Whose values  Children and adolescents Adults 
Perspective Own 
Other1 



















Mapping via regression 
analysis to anchored values 
e.g. time trade-off values 
Rescaling using anchored 
adult/young adult values for 
worst state/small numbers of 
states using DCE with 
duration, time trade-off or 
standard gamble 
Hybrid model to combine, for 
example, DCE and time 
trade-off values 
Using MAUT to 
combine, for 
example VAS and 
standard gamble 
values 
Values may be 
anchored onto 1-0 
scale directly 
where dead is 
also rated 
alongside the 




onto 1-0 scale 
directly 
Mapping via regression 
analysis to anchored values 
e.g. time trade-off values 
Rescaling using anchored 
adult/young adult values for 
worst state/small numbers of 
states using DCE with 
duration, time trade-off or 
standard gamble 
Hybrid model to combine, for 
example, DCE and time 
trade-off values 
Values may be 
anchored onto 1-0 
scale directly 
depending on VAS 
protocol used 
Using MAUT to 
combine, for 










onto 1-0 scale 
directly 
Considerations May require adult/young adult 
values to anchor onto 1-0 
scale 
VAS can be used 
for dimensions or 
states 
Often argued that 
generates 
preference not 
values as no 
consideration of 
opportunity cost 
To enable values 
on 1-0 scale and 
negative values 
must involve 
May not be deemed 
ethically acceptable 
and appropriate 




Will require other values to 
anchor onto 1-0 scale 
VAS can be used 










for use when 




inappropriate for use 
when using child 
and adolescent 
perspective 
May not be 
appropriate for 
online administration 
Whose values  Children and adolescents Adults 
rating of dead 
alongside the 








Notes: BWS: best-worst scaling; DCE: discrete choice experiment; VAS: visual analogue scale; MAUT: multiattribute utility theory; CAPI:  
computer assisted personal interview. 1This would be another person, for example another child or adolescent. 
 
  
Table 3: Summary of the value set methodologies of child and adolescent-specific generic preference-based measures 








onto 1-0 full 
health-dead 
scale 




















onto the 1-0 
scale 
[14]  2012 312 Participants 
recruited via word-










Adolescents Own health Time 
trade-off 










onto the 1-0 
scale 
[16]  2010 279 Not specified Not 
specified 






a sample of 
young adults 












a sample of 
young adults 















Own health Discrete 
choice 
experiment 




[24] 2018 1276 Participants 














onto 1-0 full 
health-dead 
scale 






























onto the 1-0 
scale 





EQ-5D-Y US Adult 
general 
population 










for x years 
followed 
by full 
health for y 
years 






[29] 2016 4155 Participants 




online panel of 
general population  
18 
upwards 























onto the 1-0 
scale 
[30] 1996 194 Parents of 
childhood cancer 
patients, and 
parents of similarly 
aged school 
children from the 
general population 













onto 1-0 full 
health-dead 
scale 




























onto the 1-0 
scale 
[31] 2005 176 Not specified, 




HUI3 Canada Adult 
general 
population 













onto the 1-0 
scale 










QWB US Adult 
general 
population 





[33] 2008 430 Local sample 
recruited in 
primary care 




16D Finland Adolescents 
aged 12-15 










17D Finland Parents 8-11 year 
old child 
VAS Unclear Value of 
dead elicited 
on VAS 
[35] 1996 115 School children, 
patients 
8-11 
 
